|Year : 1988 | Volume
| Issue : 1 | Page : 34
Recent non-surgical approach in the treatment of chalazion
Pawan Kumar Jain, Vijay Misuria
305, Thaterwara Street Meerut City-250 002 (U.P.), India
Pawan Kumar Jain
305, Thaterwara Street Meerut City-250 002 (U.P.)
Source of Support: None, Conflict of Interest: None
21 patients with 25 chalazia were treated with intra-lesional triamcinolone acetonide injection. 56% lesions resolved after a single injection while 32% after a second injection. 12% lesions required incision and curettage. No case was associated with any complication. The procedure is quick, cheap, safe, convenient and an effective alternative to conventional surgery.
|How to cite this article:|
Jain PK, Misuria V. Recent non-surgical approach in the treatment of chalazion. Indian J Ophthalmol 1988;36:34
|How to cite this URL:|
Jain PK, Misuria V. Recent non-surgical approach in the treatment of chalazion. Indian J Ophthalmol [serial online] 1988 [cited 2021 May 6];36:34. Available from: https://www.ijo.in/text.asp?1988/36/1/34/26166
| Introduction|| |
A chalazion is a chronic granuloma of the meibomian glands. The chief effects are cosmetic disfigurement with variable discomfort The standard treatment of chalazion is by incision and curettage, although spontaneous resolution may take place in a few patients. This surgical procedure although minor, some distress and discomfort to the patients is always there and often necessitates the use of pad and bandage after the surgery. The aim of this study was to evaluate the efficacy of intralesional corticosteroid therapy of chalazion.
| Material & Methods|| |
A total of 21 patients of chalazion were studied who had come to the eye out patient for the treatment Injection triamcinolone acetonide - 10 mg per ml. was used for intralesional injection. The conjunctiva was anaesthetized with xylocaine - 4%. The injection was given with a 1 ml tuberculin syringe fitted with a 25-gauge needle. A chalazion clamp was gently placed around the mass and the lid was everted. A volume of 0.02 to 0.2 ml of the triamcinolone acetonide suspension was injected into the centre of the lesion from the conjunctival surface, the amount depending upon the size of the chalazion In patients with more than one chalazion all were injected in the same sitting The clamp was removed. The eye was not padded after the procedure.
Patients were re-examined after one week, two weeks and four weeks. If the swelling had not reduced to half its original size in seven days a second injection was given. The eye was photographed during each visit
| Observation|| |
Four patients had two chalazia, so the total number of chalazia treated was twenty-five. Of the 25 injected lesions 22 (88%) resolved completely, though 8 (32%) required a second injection The chalazia that did not respond were quite hard in consistency and were present for over six months. Not a single patient had shown any complication.
| Discussion|| |
Inj. Triamcinolone acetonide (10 mg/ ml) is routinely used for the treatment of a wide variety of acute and chronic inflammatory conditions of the skin like acne cysts, psoriatic plaques, and lichen planus (1, 2, 3). It has been used for the treatment of chalazion in some previous trials (4, 5, 6, 7, 8, 9). The only complication reported was a yellow deposit in the skin of a black patient in which case the injection was given by the transcutaneous approach The transconjunctival approach adopted in this trial eliminates this complication too.
The present study shows that intralesional triamcinolone acetonide is effective in resolving chalazia which are soft to firm in consistency and which are not present for a long duration.
The advantages of this method over conventional surgery are that it is simple and cheap, requires no special instruments, and is convenient for both doctor and patient Patching of the eye is not needed and the entire procedure require less than five minutes. Multiple chalazia in eyelids of both sides can be treated in the same sitting This type of treatment is specially suitable for the chalazion near the medial canthus to avoid damage to the lacrimal canaliculus.
The disadvantage of this procedure is that roughly onethird of the cases (32%) required a second injection and a small proportion of cases (12%) required incision and curettage.
| References|| |
Moschella SL Pillsbury DM, Hurley HA Dermatology. Philadelphia Saunders, 1975 : 1134.
Plewing G, Kligman A Acne, Morpholgenesis and treatment New York: Springer, 1975:294.
Fitzpatrick TB, Arndt Ka, Clark WH, Eisen Az, Van Scot EJ, Vaughn JA, Dermatology in general medicine. New York: Mc Graw-Hill, 1971: 364.
Pizzarello LD, Jackobiea FA, Hofeldt AJ, Podolsky MM, Silvers DN. Intralesional corticosteroid therapy of chalazia. Am J. Ophthal. 1978; 85: 818-21.
Dua H, Nilawar DV. Nonsurgical therapy of chalazion. Am J Ophthal 1982; 94: 424-5.
Palva J, Pohganpetto PEJ. Intralesional conticosteroid injection for the treatment of chalazia Acta Ophthal (Kbh) 1983; 61 : 933-7.
Castren J. Stenborg T. Corticosteroid injection of chalazia Acta Ophthal 00h) 1983; 61 : 938-42.,
Watson AP, Austin DJ. Treatment of chalazion with injection of a steroid suspension. Brit J. Ophthal 1984; 68: 833-35.
Jacobs PM, Thaller VT, Wong D Intra lesional corticosteroid therapy of chalazia. Brit J. Ophthal 1984; 68: 836-37.